320 related articles for article (PubMed ID: 25162666)
1. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.
Eastell R; Brandi ML; Costa AG; D'Amour P; Shoback DM; Thakker RV
J Clin Endocrinol Metab; 2014 Oct; 99(10):3570-9. PubMed ID: 25162666
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.
Eastell R; Arnold A; Brandi ML; Brown EM; D'Amour P; Hanley DA; Rao DS; Rubin MR; Goltzman D; Silverberg SJ; Marx SJ; Peacock M; Mosekilde L; Bouillon R; Lewiecki EM
J Clin Endocrinol Metab; 2009 Feb; 94(2):340-50. PubMed ID: 19193909
[TBL] [Abstract][Full Text] [Related]
3. Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.
Silverberg SJ; Clarke BL; Peacock M; Bandeira F; Boutroy S; Cusano NE; Dempster D; Lewiecki EM; Liu JM; Minisola S; Rejnmark L; Silva BC; Walker MD; Bilezikian JP
J Clin Endocrinol Metab; 2014 Oct; 99(10):3580-94. PubMed ID: 25162667
[TBL] [Abstract][Full Text] [Related]
4. The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.
Udelsman R; Åkerström G; Biagini C; Duh QY; Miccoli P; Niederle B; Tonelli F
J Clin Endocrinol Metab; 2014 Oct; 99(10):3595-606. PubMed ID: 25162669
[TBL] [Abstract][Full Text] [Related]
5. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop.
Bilezikian JP; Brandi ML; Eastell R; Silverberg SJ; Udelsman R; Marcocci C; Potts JT
J Clin Endocrinol Metab; 2014 Oct; 99(10):3561-9. PubMed ID: 25162665
[TBL] [Abstract][Full Text] [Related]
6. Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism.
Marcocci C; Bollerslev J; Khan AA; Shoback DM
J Clin Endocrinol Metab; 2014 Oct; 99(10):3607-18. PubMed ID: 25162668
[TBL] [Abstract][Full Text] [Related]
7. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop.
Bilezikian JP; Khan AA; Potts JT;
J Clin Endocrinol Metab; 2009 Feb; 94(2):335-9. PubMed ID: 19193908
[TBL] [Abstract][Full Text] [Related]
8. Letter to the editor: Thiazides are not inducers of PTH secretion: a comment on normocalcemic hyperparathyroidism.
Yacobi-Bach M; Serebro M; Greenman Y; Tordjman K; Stern N
J Clin Endocrinol Metab; 2015 Feb; 100(2):L27-8. PubMed ID: 25658164
[No Abstract] [Full Text] [Related]
9. Letter to the editor: Distinguishing typical primary hyperparathyroidism from familial hypocalciuric hypercalcemia by using an index of urinary calcium.
Marx SJ
J Clin Endocrinol Metab; 2015 Feb; 100(2):L29-30. PubMed ID: 25658165
[No Abstract] [Full Text] [Related]
10. Further insights into the pathogenesis of primary hyperparathyroidism: a nested case-control study.
Rejnmark L; Amstrup AK; Mollerup CL; Heickendorff L; Mosekilde L
J Clin Endocrinol Metab; 2013 Jan; 98(1):87-96. PubMed ID: 23150677
[TBL] [Abstract][Full Text] [Related]
11. Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.
Silverberg SJ; Lewiecki EM; Mosekilde L; Peacock M; Rubin MR
J Clin Endocrinol Metab; 2009 Feb; 94(2):351-65. PubMed ID: 19193910
[TBL] [Abstract][Full Text] [Related]
12. Serum calcium (S-Ca), the forgotten test: preliminary results of an appropriateness strategy to detect primary hyperparathyroidism (pHPT).
Salinas M; López-Garrigós M; Pomares F; Lugo J; Asencio A; López-Penabad L; Dominguez JR; Leiva-Salinas C
Bone; 2013 Sep; 56(1):73-6. PubMed ID: 23707628
[TBL] [Abstract][Full Text] [Related]
13. Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.
Khan A; Grey A; Shoback D
J Clin Endocrinol Metab; 2009 Feb; 94(2):373-81. PubMed ID: 19193912
[TBL] [Abstract][Full Text] [Related]
14. [Primary hyperparathyroidism: new concepts, new recommendations].
Crouzeix G; Kerlan V
Ann Endocrinol (Paris); 2014 Oct; 75 Suppl 1():S21-36. PubMed ID: 25617920
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D and primary hyperparathyroidism (PHPT).
Souberbielle JC; Bienaimé F; Cavalier E; Cormier C
Ann Endocrinol (Paris); 2012 Jun; 73(3):165-9. PubMed ID: 22677209
[TBL] [Abstract][Full Text] [Related]
16. A pilot study to examine the management of asymptomatic hyperparathyroidism in Japanese patients in accordance with the guidelines for asymptomatic PHPT proposed at the Third International Workshop in 2008.
Ogo A; Sakaki Y; Saito R; Sakamoto R; Matoba Y
Intern Med; 2014; 53(16):1749-54. PubMed ID: 25130104
[TBL] [Abstract][Full Text] [Related]
17. Primary hyperparathyroidism: Update on presentation, diagnosis, and management in primary care.
Pallan S; Khan A
Can Fam Physician; 2011 Feb; 57(2):184-9. PubMed ID: 21321169
[TBL] [Abstract][Full Text] [Related]
18. Different PTH response to oral peptone load and oral calcium load in patients with normocalcemic primary hyperparathyroidism, primary hyperparathyroidism, and healthy subjects.
Invernizzi M; Carda S; Righini V; Baricich A; Cisari C; Bevilacqua M
Eur J Endocrinol; 2012 Oct; 167(4):491-7. PubMed ID: 22872468
[TBL] [Abstract][Full Text] [Related]
19. An overview of normocalcemic primary hyperparathyroidism.
Pawlowska M; Cusano NE
Curr Opin Endocrinol Diabetes Obes; 2015 Dec; 22(6):413-21. PubMed ID: 26512768
[TBL] [Abstract][Full Text] [Related]
20. [Primary hyperparathyroidism - new clinical forms of the disease].
Zajíčková K
Vnitr Lek; 2017; 63(9):604-608. PubMed ID: 29120658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
